2013
DOI: 10.1002/art.37990
|View full text |Cite
|
Sign up to set email alerts
|

Review: The Role of MicroRNAs in Osteoarthritis and Chondrogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
89
0
3

Year Published

2014
2014
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 108 publications
(93 citation statements)
references
References 105 publications
(182 reference statements)
1
89
0
3
Order By: Relevance
“…6 7 Aberrant miRNA expression or dysregulation of miRNA processing has been linked to many pathologies, including cancer, cardiovascular or rheumatic disease. [7][8][9] Since miRNA are protected from RNAse activity in the peripheral blood, miRNAs may serve as excellent biomarkers for physiological and pathological processes. 10 11 Although dysregulated miRNA expression has been well documented in the osteoarthritic cartilage, 9 12-17 evidence on altered circulating miRNA levels in OA patients is very limited.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…6 7 Aberrant miRNA expression or dysregulation of miRNA processing has been linked to many pathologies, including cancer, cardiovascular or rheumatic disease. [7][8][9] Since miRNA are protected from RNAse activity in the peripheral blood, miRNAs may serve as excellent biomarkers for physiological and pathological processes. 10 11 Although dysregulated miRNA expression has been well documented in the osteoarthritic cartilage, 9 12-17 evidence on altered circulating miRNA levels in OA patients is very limited.…”
Section: Introductionmentioning
confidence: 99%
“…[7][8][9] Since miRNA are protected from RNAse activity in the peripheral blood, miRNAs may serve as excellent biomarkers for physiological and pathological processes. 10 11 Although dysregulated miRNA expression has been well documented in the osteoarthritic cartilage, 9 12-17 evidence on altered circulating miRNA levels in OA patients is very limited. 18 19 Hence, our project is the first to investigate the differential expression of circulating miRNAs in subjects with and without incident OA in a large prospective population-based cohort.…”
Section: Introductionmentioning
confidence: 99%
“…The level of expressed miRNAs of interest, rno-miR-199a-3p, rno-miR-181a-5p, rno-miR-140-3p and rno-miR-27b- Figure 5A and 5B). It have been reported that miR-140 is specifically expressed in cartilage tissue to activate or supress PDGF, SOX9, Sp1, aggrecan, VEGF and HDAC4 [28,41]. Several miRNAs including miR-140, miR-199a, mir-193 and mir-29a/29b control the anabolic and catabolic regulation in cartilage [42].…”
Section: Principal Component Analysis and Relationship Of Mirnasmentioning
confidence: 99%
“…These studies started with an investigation of the epigenetic regulation of the expression of genes coding for proteins that have a known central role in the homeostasis of joint tissue, and in particular cartilage (14). There have also been direct investigations of the differences in expression levels of regulatory RNAs between OA and non-OA cells, the aim being to identify key RNAs that could initiate or exacerbate disease development (15,16). The advent of high-throughput CpG DNA methylation arrays has enabled investigators to directly compare, at a genome-wide level, OA and non-OA methylomes and to compare methylation status between DNA from different sites within the joint and between different joints (17)(18)(19)(20)(21)(22).…”
Section: Epigenetics and Oamentioning
confidence: 99%